Frequency and prognosis of HER2-low status in Mexican patients with metastatic breast cancer

被引：1
|
作者：
Martinez-Cannon, Bertha Alejandra
Verduzco-Aguirre, Haydee Cristina
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P3-05-58
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-05-58
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Genomic landscape of circulating tumor DNA in HER2-low metastatic breast cancer
    Yi, Zongbi
    Feng, Kaixiang
    Lv, Dan
    Guan, Yanfang
    Shao, Youcheng
    Ma, Fei
    Xu, Binghe
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [32] Neoadjuvant chemotherapy ef fi cacy and prognosis in HER2-low and HER2-zero breast cancer patients by HR status: a retrospective study in China
    Zhao, Shaorong
    Wang, Yuyun
    Zhou, Angxiao
    Liu, Xu
    Zhang, Yi
    Zhang, Jin
    PEERJ, 2024, 12
  • [33] Clinical outcomes in women with metastatic HER2-Low breast cancer in the real world
    Jiang, Changchuan
    Perimbeti, Stuthi
    Deng, Lei
    Shapiro, Charles L.
    Gandhi, Shipra
    CANCER RESEARCH, 2022, 82 (12)
  • [34] Prognostic value of HER2-low expression according to hormone receptor status in breast cancer patients
    Huszno, J.
    Kolosza, Z.
    Stobiecka, E.
    Ponikiewska, D.
    Szczesniak, B.
    Simek, J.
    Chmielik, E.
    BREAST, 2025, 80
  • [35] Trastuzumab Deruxtecan in HER2-Low Breast Cancer
    Schnog, John-John B.
    Samson, Michael J.
    Duits, Ashley J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (12): : 1143 - 1144
  • [36] Overall survival in breast cancer patients with HER2-low status single- center experience
    Huszno, J.
    Kolosza, Z.
    Stobiecka, E.
    Ponikiewska, D.
    Szczesniak, B.
    Simek, J.
    Chmielik, E.
    ANNALS OF ONCOLOGY, 2023, 34 : S1190 - S1190
  • [37] HER2-low status discordance between primary and recurrent/metastatic breast cancer in a large-scale cohort
    Lin, Mingxi
    Luo, Ting
    Zhang, Hui
    Yang, Wentao
    Zhang, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Biology and Treatment of HER2-Low Breast Cancer
    Nicolo, Eleonora
    Tarantino, Paolo
    Curigliano, Giuseppe
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 117 - 132
  • [39] HER2-Low Breast Cancer: a New Subtype?
    Chiara Corti
    Federica Giugliano
    Eleonora Nicolò
    Paolo Tarantino
    Carmen Criscitiello
    Giuseppe Curigliano
    Current Treatment Options in Oncology, 2023, 24 : 468 - 478
  • [40] Clinical Significance of HER2-low Breast Cancer
    Zaiem, Fadi
    AbuJamea, Asem
    Kheil, Mira
    Numi, Anna
    Abbas, Omar
    Awada, Sanaa
    Almsaddi, Ragad
    Al-Juburi, Saleh
    Larson, Lauren
    Jain, Deepti
    AlSaghir, Maya
    Jang, Hyejeong
    Kim, Seongho
    Bandyopadhyay, Sudeshna
    Jaiman, Sunil
    Ali-Fehmi, Rouba
    CANCER RESEARCH, 2024, 84 (09)
12345